Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B

Hepatitis B virus (HBV) RNA in serum is a novel biomarker that reflects cccDNA activity. We investigated whether HBV RNA can predict serological response to peginterferon (PEG‐IFN) treatment. Serum HBV RNA levels were retrospectively measured at weeks 0, 12, 24 and 52 of therapy and after treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: van Campenhout, Margo J. H., van Bömmel, Florian, Pfefferkorn, Maria, Fischer, Janett, Deichsel, Danilo, Boonstra, André, van Vuuren, Anneke J., Berg, Thomas, Hansen, Bettina E., Janssen, Harry L. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383601/
https://www.ncbi.nlm.nih.gov/pubmed/32052503
http://dx.doi.org/10.1111/jvh.13272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383601/
https://www.ncbi.nlm.nih.gov/pubmed/32052503
http://dx.doi.org/10.1111/jvh.13272

Ejemplares similares